All in One Therapeutics is categorized under Home Health Care Services in Elk Grove Village, IL .
All in One Therapeutics was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact George Enciso, Manager at the company’s single location by writing to 1550 East Higgins Road # 104, Elk Grove Village, Illinois IL 60007 or by phoning (847) 258-4961. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | All in One Therapeutics |
Contact Person: | George Enciso, Manager |
Address: | 1550 East Higgins Road # 104, Elk Grove Village, Illinois 60007 |
Phone Number: | (847) 258-4961 |
Annual Revenue (USD): | $100.000 to $499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Home Health Care Services |
SIC Code: | 8082 |
NAICS Code: | 6216100 |
Share This Business: |
All in One Therapeutics was started in 0 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact George Enciso, Manager for inquiries that concern All in One Therapeutics by calling the company number (847) 258-4961, as your correspondence is most welcome. Additionally, the physical location of the single location of All in One Therapeutics can be found at the coordinates 42.02333,-87.96361 as well as the street address 1550 East Higgins Road # 104 in Elk Grove Village, Illinois 60007.
For its online presence, you may visit All in One Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.